Drugs · Entity Annotation Prototype (beta)

4articles mentioning drugs

11drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Adiponectin ×

Adiponectin

This drug is selected. Its supporting articles are shown below.

Adiponectin4

Articles mentioning Adiponectin

4 articles · page 1 of 1

Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin

bmjdrc · full text · 2026-01-27 · 7 matching annotations

91.5%

statins adiponectin corticosteroids fibrates laminin sASGR1

…cations affecting liver metabolism or lipid metabolism, such as statins, fibrates, or corticosteroids within the past 3 months.Sample s…

Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes

lupusscimed · abstract · 2026-02-19 · 2 matching annotations

88.9%

adiponectin PF4 lupus nephritis

…1.16 (1.02–1.32), p=0.02), MCP-1 (HR 1.33 (1.01–1.74), p=0.04), adiponectin (HR 2.67 (1.68–2.46), p<0.001) and PF4 (HR 1.14 (1.04–1.25), p=…

Adipokines and mortality in burns and traumatic brain injury

tsaco · abstract · 2026-03-23 · 1 matching annotations

89.0%

leptin Adipokines resistin Adipokine visfatin adiponectin burns

… −1.26, leptin −1.01, respectively) and at admission after TBI (leptin −1.51, visfatin −1.44, adiponectin −1.51, and resistin −1.29, a…

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement

gutjnl · abstract · 2026-01-21 · 1 matching annotations

79.8%

GLP-1 receptor agonists leptin adiponectin CRC colorectal cancer bariatric surgery MASLD Metabolic dysfunction-associated steatotic liver disease lifestyle interventions

…nterventions, early CRC screening, bariatric surgery and use of GLP-1 receptor agonists are highlighted as potential risk-reduction strategies.Conclusi…